Drug Type Small molecule drug |
Synonyms 1-(2-(bis(p-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine, Boxeprazine, Vanoxerine + [3] |
Target |
Action modulators |
Mechanism DAT modulators(Dopamine transporter modulators), SERT modulators(Serotonin transporter modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC28H34Cl2F2N2O |
InChIKeyMIBSKSYCRFWIRU-UHFFFAOYSA-N |
CAS Registry67469-78-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Vanoxerine Hydrochloride | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atrial Fibrillation | Phase 3 | United States | 01 Sep 2015 | |
Atrial Fibrillation | Phase 3 | Bulgaria | 01 Sep 2015 | |
Atrial Fibrillation | Phase 3 | Hungary | 01 Sep 2015 | |
Atrial Fibrillation | Phase 3 | Israel | 01 Sep 2015 | |
Atrial Fibrillation | Phase 3 | Russia | 01 Sep 2015 | |
Atrial fibrillation and flutter | Phase 3 | United States | 01 Sep 2015 | |
Atrial fibrillation and flutter | Phase 3 | Bulgaria | 01 Sep 2015 | |
Atrial fibrillation and flutter | Phase 3 | Hungary | 01 Sep 2015 | |
Atrial fibrillation and flutter | Phase 3 | Israel | 01 Sep 2015 | |
Atrial fibrillation and flutter | Phase 3 | Russia | 01 Sep 2015 |
Phase 3 | 41 | (Vanoxerine HCl) | nvsmejvyla = hbikynscww bxoglgejfu (ditzaoqnaa, acctwufqsi - hwqvsylrfj) View more | - | 17 Oct 2016 | ||
Placebo (Placebo) | nvsmejvyla = ytdllvnrhb bxoglgejfu (ditzaoqnaa, zjoufshphv - iltkpbnewy) View more | ||||||
Phase 2 | 104 | Placebo (Placebo) | xyrkjgwiie = jxkiekplam fvjxibhjsb (yiqkohbsgj, tzliejwqve - xnrbgyrofk) View more | - | 22 Dec 2015 | ||
(Vanoxerine 200mg) | xyrkjgwiie = datihcwnha fvjxibhjsb (yiqkohbsgj, zlfetvdiwd - tcbmdjcpuu) View more |